They found that the response of pediatric patients with AML and acute lymphoid leukemia (ALL) to haploidentical HSCT could be predicted by the presence of this KIR/KIR-ligand mismatch. The gene discussed is KIR3DL1; the disease is acute lymphoblastic leukemia.